Kuchyne na miru


Sep 02, 2019
As well as official European projections of sharply slowing industry growth and geopolitical concerns, pharma executives face additional hazards as they plot their medium-term strategies, writes Reflector.
Aug 22, 2019
Leela Barham talks to Sir David Haslam, the outgoing Chair of UK’s National Institute for Health and Care Excellence (NICE), about the highs and lows of his six-year tenure at the organization.
Aug 08, 2019
Pharmaceutical Executive
Exploring the EU’s struggles and new efforts in promoting cell and gene drugs.
Aug 07, 2019
Pharmaceutical Executive
Efforts in motion for cross-border sharing, but barriers are many, writes Reflector.
Jun 21, 2019
Chris Round, Head of International Operations & Global Core Franchises at Merck KGaA, Darmstadt, Germany, talks to Pharm Exec about his role in advancing the company’s “double mission."
Jun 11, 2019
Pharmaceutical Executive
With a new Commission looming, here’s who’s vying for the top spot in shaping EU strategy, including key questions in pharma.
May 30, 2019
The World Health Assembly's new resolution on transparency in the market for health-related products is weaker than the original draft but still contains measures that could have a substantial impact on market access around the world, writes Neil Grubert.
Apr 29, 2019
The UK has had in place what amount to two pricing schemes for branded medicines for years. But with major changes to both schemes set out in 2018, it’s now a new tale of two pricing schemes. Leela Barham reports.
Jan 22, 2019
“You wanna play rough? Just try it!” was the gist of the New-Year message from the European pharma industry to the healthcare authorities circling around drug firms preparing for pricing discussions. Reflector reports.
Jan 08, 2019
While more are now achieving 100% compliance, life sciences companies are still grappling with implementation of the policy and procedure changes under the GDPR, writes Ashley Williams.
красивые детские платья

удаление тату одесса

lorem ipsum